S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:SCTL

Societal CDMO (SCTL) Stock Price, News & Analysis

$1.10
+0.01 (+0.92%)
(As of 04/8/2024)
Today's Range
$1.09
$1.10
50-Day Range
$0.46
$1.10
52-Week Range
$0.26
$1.28
Volume
514,600 shs
Average Volume
957,342 shs
Market Capitalization
$116.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.80

Societal CDMO MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
63.6% Upside
$1.80 Price Target
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.69 out of 5 stars

Medical Sector

631st out of 911 stocks

Pharmaceutical Preparations Industry

269th out of 411 stocks

SCTL stock logo

About Societal CDMO Stock (NASDAQ:SCTL)

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. The company provides end-to-end services, such as formulation development focusing on complex formulations, reformulation, physical characterization, and excipient compatibility; analytical methods development which offers a range of analytical testing capabilities, including product testing, ICH stability, method development and validation, chromatography and spectroscopy equipment, stability chambers, and microbial testing; and pharmaceutical manufacturing that provides milling, blending, compression, spray and rotary granulation, particle and bead coating, encapsulation, liquids, lyophilization, and sterile fill and finish services. It also offers regulatory support, including handling communications with the food and drug administration (FDA) and seek consultation and guidance for client FDA meetings and responses; and pharmaceutical packaging and logistics, as well as smaller-scale primary and secondary packaging, labeling and kitting options suited for clinical trial materials and development packaging needs across dosage forms. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

SCTL Stock Price History

SCTL Stock News Headlines

Urgent alert: open this for a huge profit potential
This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.
Urgent alert: open this for a huge profit potential
This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.
Why Is Societal CDMO (SCTL) Stock Up 133% Today?
Societal CDMO Inc SCTL
Recap: Societal CDMO Q3 Earnings
Earnings Preview: Societal CDMO
See More Headlines
Receive SCTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Societal CDMO and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/22/2024
Today
4/20/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SCTL
Employees
258
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.80
High Stock Price Target
$2.50
Low Stock Price Target
$1.10
Potential Upside/Downside
+63.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-13,270,000.00
Pretax Margin
-13.89%

Debt

Sales & Book Value

Annual Sales
$94.64 million
Book Value
$0.56 per share

Miscellaneous

Free Float
97,658,000
Market Cap
$116.26 million
Optionable
Optionable
Beta
1.61
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Wayne B. Weisman J.D. (Age 68)
    Executive Chairman of the Board
    Comp: $85k
  • Mr. J. David Enloe Jr. (Age 60)
    President, CEO & Director
    Comp: $1.02M
  • Mr. Ryan D. Lake CPA (Age 47)
    Senior VP & CFO
    Comp: $716.26k
  • Mr. Marshall Rizzo M.B.A.
    Senior VP & COO
  • Mr. Richard Sidwell Ph.D.
    Senior VP & Chief Scientific Officer
  • Ms. Cristin Grove
    Vice President of Sales
  • Ms. Erica Raether M.A.
    Senior VP & Chief People Officer

SCTL Stock Analysis - Frequently Asked Questions

Should I buy or sell Societal CDMO stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Societal CDMO in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SCTL shares.
View SCTL analyst ratings
or view top-rated stocks.

What is Societal CDMO's stock price target for 2024?

3 Wall Street research analysts have issued 12-month target prices for Societal CDMO's shares. Their SCTL share price targets range from $1.10 to $2.50. On average, they expect the company's share price to reach $1.80 in the next twelve months. This suggests a possible upside of 63.6% from the stock's current price.
View analysts price targets for SCTL
or view top-rated stocks among Wall Street analysts.

How have SCTL shares performed in 2024?

Societal CDMO's stock was trading at $0.3505 on January 1st, 2024. Since then, SCTL stock has increased by 213.8% and is now trading at $1.10.
View the best growth stocks for 2024 here
.

Are investors shorting Societal CDMO?

Societal CDMO saw a drop in short interest in March. As of March 31st, there was short interest totaling 2,400 shares, a drop of 99.1% from the March 15th total of 271,500 shares. Based on an average daily volume of 7,100 shares, the short-interest ratio is presently 0.3 days.
View Societal CDMO's Short Interest
.

When is Societal CDMO's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our SCTL earnings forecast
.

How were Societal CDMO's earnings last quarter?

Societal CDMO, Inc. (NASDAQ:SCTL) announced its earnings results on Friday, March, 22nd. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $27.72 million during the quarter, compared to analysts' expectations of $25.50 million. Societal CDMO had a negative trailing twelve-month return on equity of 23.82% and a negative net margin of 14.03%.

How do I buy shares of Societal CDMO?

Shares of SCTL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SCTL) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners